| Financial Year |
March 31 2023 |
| Monetary Funds |
729,362,901.71 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
455,483,552.70 |
| Advances to Suppliers |
298,904,486.06 |
| Other Receivables |
27,522,890.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
405,656,914.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,925,563.17 |
| Other Current Assets |
23,115,410.40 |
| Total Current Assets |
2,050,455,403.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
103,284,815.46 |
| Long-term Equity Investment |
1,030,916,787.35 |
| Investment Properties |
71,291,283.00 |
| Fixed Assetes |
1,933,711,604.46 |
| Under-construction Projects |
140,247,650.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,160,269.27 |
| R&D expenses |
2,008,171.49 |
| Goodwill |
1,198,342,453.12 |
| Long-Term Deferred and Prepaid Expenses |
10,585,161.68 |
| Deferred Income Tax Assets |
137,077,554.40 |
| Other Non-Current Assets |
19,259,583.18 |
| Sub-Total of Non-Current Assets |
4,976,252,981.20 |
| Total Assets |
7,026,708,385.07 |
| Short-Term Loans |
1,290,214,130.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
687,166,395.64 |
| Accounts Payable |
348,106,297.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,775,662.52 |
| Taxes Payable |
25,490,565.67 |
| Interest Payable |
-- |
| Dividend Payable |
9,080,514.72 |
| Other payables |
53,635,644.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
384,884,406.22 |
| Other Current Liabilities |
41,839,410.32 |
| Sub-Total of Current Liabilities |
3,357,710,675.72 |
| Long-term Loans |
287,648,680.71 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
60,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
113,956,827.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
538,901,789.36 |
| Total Liabilities |
3,896,612,465.08 |
| Paid-In Capital(Or Share Stock) |
880,084,656.00 |
| Capital Surplus |
952,518,616.23 |
| Surplus Reserve |
163,556,746.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
701,557,912.85 |
| Minority Stockholder's Interest |
377,649,393.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,752,446,526.60 |
| Owner's Equity（Stockholder's Equity） |
3,130,095,919.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,026,708,385.07 |
